Bravecto Plus

Authorised

This medicine is authorised for use in the European Union

fluralaner / moxidectin

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Bravecto Plus : EPAR - Medicine overview

Product information

Bravecto Plus : EPAR - Product Information

Bravecto Plus : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Bravecto Plus
• Active substance:
  • fluralaner
  • moxidectin
• International non-proprietary name (INN) or common name:
  • fluralaner
  • moxidectin

Pharmacotherapeutic group

• Antiparasitic products, insecticides and repellents
• Endectocides
• Milbemycins

Authorisation details

• EMA product number:
  EMEA/V/C/004440

Assessment history

Changes since initial authorisation of medicine

Bravecto Plus : EPAR - Procedural steps taken and scientific information after authorisation

CVMP post-authorisation summary of positive opinion for Bravecto Plus (VRA)

Adopted Reference Number: EMA/CVMP/51467/2023

Bravecto Plus-H-C-4440-II-0006: EPAR - Assessment Report- Variation

Adopted

CVMP post-authorisation summary of positive opinion Bravecto Plus (II-0006)

Adopted Reference Number: EMA/CVMP/599149/2019

Bravecto Plus-H-C-4440-II-0003: EPAR - Assessment Report- Variation

Adopted

CVMP post-authorisation summary of positive opinion for Bravecto Plus

Adopted Reference Number: EMA/CVMP/256330/2019

Initial marketing authorisation documents

Bravecto Plus : EPAR - Public assessment report

Adopted

CVMP summary of positive opinion for Bravecto Plus

Adopted Reference Number: EMA/CVMP/35302/2018